HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Agius Selected Research

Monoclonal Antibodies

1/2019Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Agius Research Topics

Disease

6Multiple Sclerosis
01/2020 - 01/2011
4Myasthenia Gravis
12/2012 - 09/2003
2Relapsing-Remitting Multiple Sclerosis
01/2020 - 06/2014
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020
1Fever (Fevers)
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Neoplasms (Cancer)
06/2014
1Bradycardia
06/2014
1Basal Cell Carcinoma (Rodent Ulcer)
06/2014
1Atrioventricular Block
06/2014
1Herpes Zoster
06/2014
1Hypertension (High Blood Pressure)
06/2014
1Infections
06/2014
1Lymphopenia (Lymphocytopenia)
06/2014
1Autoimmune Diseases (Autoimmune Disease)
03/2014
1Inflammation (Inflammations)
03/2014
1Thymus Hyperplasia
12/2012
1Muscle Weakness
04/2012
1Weight Loss (Weight Reduction)
04/2012
1Disease Progression
12/2004

Drug/Important Bio-Agent (IBA)

3AntigensIBA
03/2014 - 09/2003
2Pharmaceutical PreparationsIBA
01/2019 - 01/2011
2Phosphotransferases (Kinase)IBA
12/2012 - 04/2012
2muskIBA
12/2012 - 04/2012
2AntibodiesIBA
04/2012 - 12/2003
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2003 - 09/2003
1Interferon beta-1aFDA Link
01/2020
1Alemtuzumab (Campath)FDA Link
01/2020
1Inosine Triphosphate (ITP)IBA
01/2020
1Monoclonal AntibodiesIBA
01/2019
1inebilizumabIBA
01/2019
1Alanine Transaminase (SGPT)IBA
06/2014
1Fingolimod Hydrochloride (FTY720)FDA Link
06/2014
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2014
1Indicators and Reagents (Reagents)IBA
03/2014
1CytokinesIBA
03/2014
1HLA-DRB5 Chains (HLA DRB5)IBA
04/2013
1HLA-DRB1 Chains (HLA DRB1)IBA
04/2013
1Cholinesterase Inhibitors (Anticholinesterases)IBA
12/2012
1Proteins (Proteins, Gene)FDA Link
04/2012
1Cholinergic ReceptorsIBA
04/2012
1Recombinant DNA (Recombinant DNA Research)IBA
01/2011

Therapy/Procedure

2Therapeutics
01/2020 - 12/2004
1Immunotherapy
03/2014